SKU: UB-TESA-10mg

UB-TESA (10mg)

UB-TESA is a synthetic 44-residue analogue of growth hormone-releasing hormone. It shares the core amino acid sequence of the endogenous peptide and carries a trans-3-hexenoyl modification at the N-terminal tyrosine.

In published literature, the N-terminal modification has been described as increasing resistance to enzymatic degradation compared with native GHRH. This material is supplied as a characterized reference compound for non-clinical laboratory work, such as analytical method development, GHRH receptor binding and signaling assays, and comparative stability studies of GHRH analogues.

Chemical & Formula Details

Sequence (three-letter): (trans-3-hexenoyl)-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu-NH₂
Molecular Formula: C₂₂₃H₃₇₀N₇₂O₆₉S
Molecular Weight: ~5195.9 g/mol
PubChem CID: 44147413
CAS Number: 901758-09-6

Storage & Handling
Store at −20 °C, protected from light. Avoid moisture and repeated freeze-thaw cycles. Handle in accordance with standard laboratory safety practices.

FOR RESEARCH USE ONLY. Not for human consumption. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug, food or cosmetic.

$99.00

UB-TESA (10mg)

Batch Documentation

COA / Lab Reports

2 reports

Current Lot

Current Lot NA

LotNA

COA DateSep 3, 2026

Purity99.71%

Current Lot

Current Lot 2282026

Lot2282026

COA DateJan 6, 2026

Purity99.8%

Description
Additional information

Description

UB-TESA is a synthetic 44-residue analogue of growth hormone-releasing hormone. It shares the core amino acid sequence of the endogenous peptide and carries a trans-3-hexenoyl modification at the N-terminal tyrosine.

In published literature, the N-terminal modification has been described as increasing resistance to enzymatic degradation compared with native GHRH. This material is supplied as a characterized reference compound for non-clinical laboratory work, such as analytical method development, GHRH receptor binding and signaling assays, and comparative stability studies of GHRH analogues.

Chemical & Formula Details

Sequence (three-letter): (trans-3-hexenoyl)-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu-NH₂
Molecular Formula: C₂₂₃H₃₇₀N₇₂O₆₉S
Molecular Weight: ~5195.9 g/mol
PubChem CID: 44147413
CAS Number: 901758-09-6

Storage & Handling
Store at −20 °C, protected from light. Avoid moisture and repeated freeze-thaw cycles. Handle in accordance with standard laboratory safety practices.

FOR RESEARCH USE ONLY. Not for human consumption. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug, food or cosmetic.

Additional information

Weight	0.1 lbs
Dimensions	1 × 1 × 2 in

Scientific Reviewer

Scientifically reviewed by Dr. Julian H. Park, MD. Dr. Park serves as Scientific Reviewer for Universal BioLabs, helping uphold the accuracy, credibility, and scientific rigor of all technical content and research citations. He earned his medical degree from the University of California, Irvine School of Medicine and completed residency training in family medicine at Cedars-Sinai Medical Center. With more than 20 years of clinical experience, Dr. Park reviews research citations, study interpretations, and technical content for scientific accuracy.

Disclaimer: For Research Purposes Only

This content is supplied exclusively for research and educational purposes. Nothing presented here should be interpreted as approval, promotion, or encouragement of any non-laboratory use, improper handling, or non-research application of peptides intended for scientific investigation. Any references to specific peptides, their properties, or findings associated with them are provided solely as informational research content. They are not medical advice, legal advice, clinical guidance, or a recommendation for personal, therapeutic, or non-research use. These compounds are intended only for controlled scientific work conducted by qualified and authorized individuals. Before making any decision regarding the purchase, possession, handling, or use of research peptides, appropriate consultation with qualified research professionals, medical experts, or legal counsel is strongly advised. All information should be used responsibly, ethically, and only in connection with legitimate academic, scientific, or investigative purposes. This notice applies broadly to all peptide-related content provided here and may be updated as needed.

0